BN Business News
أضف شركتك →
تجري حاليًا ترجمة هذا المقال. نعرض مؤقتًا النسخة الأصلية باللغة الإنجليزية.

التجارة الدولية · 25‏/6‏/20041 دقائق للقراءة

In the Matter of Certain Injectable Implant Compositions; Notice of Investigation

ترجمة آلية محلية · اللغة الأصلية للمصدر

الملخص

Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on May 26, 2004 under section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, on behalf of Inamed Corporation of Santa Barbara, California. An amended complaint was filed on June 16, 2004, and a letter supplementing the amended complaint was filed on June 17, 2004. The amended complaint alleges violations of section 337 in the importation into the United States, the sale for importation, and the sale within the United States after importation of certain injectable implant compositions by reason of infringement of claims 1, 2, 7, 12, 18, 20, 25, 26, 30, 31, 32, 33 and 34 of U.S. Patent No. 4,803,075. The amended complaint further alleges that an industry in the United States exists, or is in the process of being established, as required by subsection (a)(2) of section 337. The complainant requests that the Commission institute an investigation and, after the investigation, issue a permanent exclusion order and permanent cease-and-desist orders.

اللغة الأصلية للمصدر: Federal Register — International Trade Commissionافتح البيان الأصلي →

استكشف الموضوعات

تحليلات الأعمال →